BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 25160655)

  • 1. Dinuclear [{(p-cym)RuCl}2(μ-phpy)](PF6)2 and heterodinuclear [(ppy)2Ir(μ-phpy)Ru(p-cym)Cl](PF6)2 complexes: synthesis, structure and anticancer activity.
    Tripathy SK; De U; Dehury N; Pal S; Kim HS; Patra S
    Dalton Trans; 2014 Oct; 43(39):14546-9. PubMed ID: 25160655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, characterisation and biological activities of [(p-cym)RuX(pz4lut)]n+ and [{(p-cym)RuX}2(μ-pz4lut)]n+ (X = Cl, H2O and pz4lut = α,α,α',α'-tetra(pyrazol-1-yl)-2,6-lutidine).
    Tripathy SK; Surada RK; Manne RK; Mobin SM; Santra MK; Patra S
    Dalton Trans; 2013 Oct; 42(39):14081-91. PubMed ID: 23938874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
    Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
    Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photoinduced ligand exchange and DNA binding of cis-[Ru(phpy)(phen)(CH3CN)2]+ with long wavelength visible light.
    Sears RB; Joyce LE; Ojaimi M; Gallucci JC; Thummel RP; Turro C
    J Inorg Biochem; 2013 Apr; 121():77-87. PubMed ID: 23353083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cationic arene ruthenium(II) complexes with chelating P-functionalized alkyl phenyl sulfide and sulfoxide ligands as potent anticancer agents.
    Ludwig G; Kaluđerović GN; Rüffer T; Bette M; Korb M; Block M; Paschke R; Lang H; Steinborn D
    Dalton Trans; 2013 Mar; 42(11):3771-4. PubMed ID: 23340605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, characterization, and anticancer activity of ruthenium-pyrazole complexes.
    David S; Perkins RS; Fronczek FR; Kasiri S; Mandal SS; Srivastava RS
    J Inorg Biochem; 2012 Jun; 111():33-9. PubMed ID: 22484498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxicity of Ru(II) piano-stool complexes with chloroquine and chelating ligands against breast and lung tumor cells: Interactions with DNA and BSA.
    Colina-Vegas L; Villarreal W; Navarro M; de Oliveira CR; Graminha AE; Maia PIDS; Deflon VM; Ferreira AG; Cominetti MR; Batista AA
    J Inorg Biochem; 2015 Dec; 153():150-161. PubMed ID: 26277415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, characterization, interactions with 9-MeG and cytotoxic activity of heterobimetallic Ru
    Tsolis T; Nikolaou N; Ypsilantis K; Kougioumtzi A; Kordias D; Magklara A; Garoufis A
    J Inorg Biochem; 2021 Jun; 219():111435. PubMed ID: 33819801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A hypoxia efficient imidazole-based Ru(II) arene anticancer agent resistant to deactivation by glutathione.
    Purkait K; Karmakar S; Bhattacharyya S; Chatterjee S; Dey SK; Mukherjee A
    Dalton Trans; 2015 Apr; 44(13):5969-73. PubMed ID: 25742181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Cancer Cell-Selective and Low-Toxic Bifunctional Heterodinuclear Pt(IV)-Ru(II) Anticancer Prodrug.
    Ma L; Lin X; Li C; Xu Z; Chan CY; Tse MK; Shi P; Zhu G
    Inorg Chem; 2018 Mar; 57(5):2917-2924. PubMed ID: 29436828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterodinuclear Pt(iv)-Ru(ii) anticancer prodrugs to combat both drug resistance and tumor metastasis.
    Ma L; Ma R; Wang Z; Yiu SM; Zhu G
    Chem Commun (Camb); 2016 Sep; 52(71):10735-8. PubMed ID: 27506281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cis-[RuCl(BzCN)(N-N)(P-P)]PF6 complexes: Synthesis and in vitro antitumor activity: (BzCN=benzonitrile; N-N=2,2'-bipyridine; 1,10-phenanthroline; P-P=1,4-bis(diphenylphosphino) butane, 1,2-bis(diphenylphosphino)ethane, or 1,1'-(diphenylphosphino)ferrocene).
    Pereira Fde C; Lima BA; de Lima AP; Pires WC; Monteiro T; Magalhães LF; Costa W; Graminha AE; Batista AA; Ellena J; Siveira-Lacerda Ede P
    J Inorg Biochem; 2015 Aug; 149():91-101. PubMed ID: 25873134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining [arene-Ru] with azocarboxamide to generate a complex with cytotoxic properties.
    Sommer MG; Kureljak P; Urankar D; Schweinfurth D; Stojanović N; Bubrin M; Gazvoda M; Osmak M; Sarkar B; Košmrlj J
    Chemistry; 2014 Dec; 20(52):17296-9. PubMed ID: 25376425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New π-arene ruthenium(II) piano-stool complexes with nitrogen ligands.
    Grau J; Noe V; Ciudad C; Prieto MJ; Font-Bardia M; Calvet T; Moreno V
    J Inorg Biochem; 2012 Apr; 109():72-81. PubMed ID: 22387934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly active neutral ruthenium(II) arene complexes: synthesis, characterization, and investigation of their anticancer properties.
    Ludwig G; Kaluđerović GN; Bette M; Block M; Paschke R; Steinborn D
    J Inorg Biochem; 2012 Aug; 113():77-82. PubMed ID: 22698819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ru
    Lenis-Rojas OA; Robalo MP; Tomaz AI; Carvalho A; Fernandes AR; Marques F; Folgueira M; Yáñez J; Vázquez-García D; López Torres M; Fernández A; Fernández JJ
    Inorg Chem; 2018 Nov; 57(21):13150-13166. PubMed ID: 30339386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening organometallic binuclear thiosemicarbazone ruthenium complexes as potential anti-tumour agents: cytotoxic activity and human serum albumin binding mechanism.
    Demoro B; de Almeida RF; Marques F; Matos CP; Otero L; Costa Pessoa J; Santos I; Rodríguez A; Moreno V; Lorenzo J; Gambino D; Tomaz AI
    Dalton Trans; 2013 May; 42(19):7131-46. PubMed ID: 23519281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclometalated Ru(II)-isoquinoline complexes overcome cisplatin resistance of A549/DDP cells by downregulation of Nrf2 via Akt/GSK-3β/Fyn pathway.
    Chen L; Wang J; Cai X; Chen S; Zhang J; Li B; Chen W; Guo X; Luo H; Chen J
    Bioorg Chem; 2022 Feb; 119():105516. PubMed ID: 34856444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mitochondria-targeting dinuclear Ir-Ru complex as a synergistic photoactivated chemotherapy and photodynamic therapy agent against cisplatin-resistant tumour cells.
    Zhang C; Guan R; Liao X; Ouyang C; Rees TW; Liu J; Chen Y; Ji L; Chao H
    Chem Commun (Camb); 2019 Oct; 55(83):12547-12550. PubMed ID: 31576841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, characterisation and antibacterial activity of [(p-cym)RuX(L)](+/2+) (X = Cl, H2O; L = bpmo, bpms) complexes.
    Tripathy SK; Taviti AC; Dehury N; Sahoo A; Pal S; Beuria TK; Patra S
    Dalton Trans; 2015 Mar; 44(11):5114-24. PubMed ID: 25675378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.